CNBX
CNBX Pharmaceuticals Inc.Company Information
- Company Name
- CNBX Pharmaceuticals Inc.
- CIK
- CIK0001343009
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- CNBX: OTC
- Fiscal Year End
- August 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CNBX
SEC filing data through
Insider Sentiment
- Last purchase
- 2013-10-28
- Last sale
- 2014-07-25
- Shares purchased (TTM)
- 20,000,000
- Shares sold (TTM)
- 94,264,594
Institutional Sentiment
- As of
- 2024-12-31
- Institutional shares owned
- 9
- Shares outstanding
- 31,111,352
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-06-24
- Price on filing date
- —
- 1-month reaction
- -50.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Investments | - | - | - | - | - | - | - | 0 | - | - | - | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Convertible Debt Current | - | - | - | - | - | - | - | 1 | - | - | - | 1 | ||||||
| Short Term Bank Loans And Notes Payable | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Short Term Borrowings | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 23 | 23 | 23 | 23 | 23 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | ||||||
| Deferred Compensation Equity | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | - | - | - | 0 | - | 0 | - | - | - | 0 | ||||||
| Retained Earnings Accumulated Deficit | -26 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -24 | -24 | ||||||
| Other Additional Capital | - | - | - | - | - | - | - | 0 | - | - | - | 0 | ||||||
| Stockholders Equity | -3 | -3 | -3 | -2 | -3 | -3 | -3 | -2 | -2 | -2 | -2 | -2 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 100 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 900 | 900 | 900 | 900 | 900 | 900 | 900 | ||||||
| Common Stock Shares Issued | 1,476 | 1,126 | 753 | 554 | 93 | 34 | 31 | 31 | 3 | 3 | 28 | 23 | ||||||
| Shares Outstanding | 1,476 | 1,126 | 753 | 554 | 93 | 34 | 31 | 31 | 3 | 3 | 28 | 23 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCNBX Pharmaceuticals Inc. (CNBX) — SEC Financial Statements & Analysis
CNBX Pharmaceuticals Inc. (CNBX) is a pharmaceutical preparations company, incorporated in NV. CNBX Pharmaceuticals Inc. trades on OTC as: CNBX. CNBX Pharmaceuticals Inc. (CNBX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-05-31, filed with the SEC on 2026-06-24. Based on that filing, CNBX Pharmaceuticals Inc. carries a market cap of $263.72K, a P/E ratio of -0.57x, a P/B ratio of -0.10x, a P/S ratio of 5.74x, an enterprise value of $1.42M, and an EV/EBITDA multiple of -3.31x. On profitability, it posts an operating margin of -1102.63%, a net margin of -1355.97%, a Return on Equity (ROE) of 17.78%, and a Return on Assets (ROA) of -2942.32%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 105.88% year-over-year, and EPS growth of -93.35% year-over-year. On the balance sheet, it maintains a current ratio of 0.00x, a quick ratio of 0.00x, working capital of $-2.66M, a debt-to-equity ratio of -1.00x, a debt ratio of 208.87, an interest coverage ratio of -5.44x, free cash flow of $-154.17K (TTM), and net debt of $1.16M. Figures sourced from SEC EDGAR.
- Market Cap
- $263.72K
- P/E TTM
- -0.57x
- EPS TTM
- $-0.00
- P/B TTM
- -0.10x
- ROE TTM
- 17.78%
- ROA TTM
- -2942.32%
- Debt To Equity
- -1.00x
- Free Cash Flow TTM
- $-154.17K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-05-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CNBX Pharmaceuticals Inc. in?
CNBX Pharmaceuticals Inc. (CNBX) operates in the Pharmaceutical Preparations industry.
What exchange does CNBX trade on?
CNBX Pharmaceuticals Inc. (CNBX) trades on the OTC.
Where is CNBX Pharmaceuticals Inc. incorporated?
CNBX Pharmaceuticals Inc. is incorporated in NV.
When was CNBX Pharmaceuticals Inc. (CNBX)'s most recent SEC filing?
CNBX Pharmaceuticals Inc. (CNBX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-05-31, filed with the SEC on 2026-06-24.
What is CNBX's market cap?
CNBX Pharmaceuticals Inc. (CNBX) has a market capitalization of $263.72K as of 2026-05-31.
What is CNBX's EPS (earnings per share)?
CNBX Pharmaceuticals Inc. (CNBX)'s trailing twelve month EPS is $-0.00 as of 2026-05-31.
What is CNBX's ROE (return on equity)?
CNBX Pharmaceuticals Inc. (CNBX)'s trailing twelve month Return on Equity (ROE) is 17.78% as of 2026-05-31.
What is CNBX's ROA (return on assets)?
CNBX Pharmaceuticals Inc. (CNBX)'s trailing twelve month Return on Assets (ROA) is -2942.32% as of 2026-05-31.
What is CNBX's EV/EBITDA?
CNBX Pharmaceuticals Inc. (CNBX)'s trailing twelve month EV/EBITDA is -3.31x as of 2026-05-31.